In a regulatory filing, Vera Therapeutics disclosed that its director Beth Seidenberg bought 89.3K shares of common stock on March 17th in a total transaction size of $637K.
Published first on TheFly
See the top stocks recommended by analysts >>
Read More on VERA:
- 3 Stocks Insiders Love
- Vera Therapeutics director Seidenberg buys $2.2M in common stock
- Vera Therapeutics director Enright buys $12.0M in common stock
- Vera Therapeutics Announces Closing of Upsized Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares in Public Offering of Class A Common Stock
- Three new option listings and one option delisting on February 2nd